Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02512172
Title A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

colorectal cancer

Therapies

Azacitidine + Pembrolizumab

Pembrolizumab + Romidepsin

Azacitidine + Pembrolizumab + Romidepsin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.